# Selfapy

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/selfapy

- Industry: Healthcare Specialists
- Headquarters: Berlin, Germany
- Website: www.selfapy.com/
- Total disclosed funding: $7.7M
- Latest round: Series A (Dec 23, 2022)
- Investors on record: 9

## About

Based in Germany, Selfapy GmbH provides a mobile platform offering online therapy programs aimed at addressing various psychological conditions through evidence-based methods.Founded in 2016, Selfapy GmbH operates out of Berlin, Germany, and specializes in online therapeutic interventions. The company has successfully engaged in 5 funding deals, with the latest being a Series A round in March 2025, where they raised EUR 7.20 mn led by Medice Arzneimittel. This funding supports their mission to expand mental health services. Selfapy's founder, Katrin Bermbach, has a background in health technology, contributing to the firm's strategic growth.Selfapy provides online therapy programs designed to address mental health issues such as depression, generalized anxiety disorder, chronic pain, binge-eating disorder, and bulimia. Their core offering includes structured 12-week courses based on cognitive-behavioral therapy, featuring 12 lessons with user-friendly texts, videos, and interactive exercises. These programs can be accessed via prescriptions from licensed healthcare providers and are covered 100% by statutory health insurance in Germany, ensuring immediate support for those in need.Selfapy generates revenue through a B2B model where healthcare professionals prescribe the online therapy programs, allowing patients to access services without out-of-pocket costs. Reimbursements from statutory health insurance providers facilitate financial transactions primarily between Selfapy and these insurers, enhancing access to essential mental health services for patients who have valid prescriptions.In March 2025, Medice Arzneimittel acquired Selfapy GmbH, enabling them to enhance their digital health solutions and solidify their role in delivering mental health therapies. The acquisition is expected to drive future growth through new product development and strategic market expansions, although specific upcoming products and additional target markets have not been disclosed.

## Funding rounds

- Series A, Dec 23, 2022, $7.7M — SHS Gesellschaft fur Beteiligungsmanagement, High-Tech Gruenderfonds, VC Fonds Kreativwirtschaft Berlin, Think.Health Ventures, Medice Arzneimittel
- Seed, Jul 7, 2017 — IBB Ventures, High-Tech Gruenderfonds
- Seed, Jun 17, 2016 — Littlerock, Digital Health Ventures, about:seed GmbH

## Investors

- Littlerock — Seed
- Digital Health Ventures (https://capitalatlas.ai/funds/digital-health-ventures) — Seed
- about:seed GmbH — Seed
- IBB Ventures (https://capitalatlas.ai/funds/ibb-ventures) — Seed
- High-Tech Gruenderfonds (https://capitalatlas.ai/funds/high-tech-gruenderfonds) — Seed, Series A
- SHS Gesellschaft fur Beteiligungsmanagement (https://capitalatlas.ai/funds/shs-gesellschaft-fur-beteiligungsmanagement) — Series A
- VC Fonds Kreativwirtschaft Berlin — Series A
- Think.Health Ventures (https://capitalatlas.ai/funds/think-health-ventures) — Series A
- Medice Arzneimittel — Series A